Su N Aung, MD
Infectious Disease · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 3
- Since medical school
- 13 years
- Graduated 2013
Offices
3 locations · Regents of the University of California · University of California San Francisco
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aung’s office at (415) 476-4029 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A169620 · Current
Licensed to practise in California · since 2020 · expires 2028-08-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Infectious Disease
- American Board of Internal Medicine - Internal Medicine
- American Board of Pediatrics - Pediatrics
Original Medicare doctor bills
$14,587
Medicare paid this office $14,587 for 76 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 32 | $6,128 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,298 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $2,018 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,262 | $115 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 14 | $430 | $31 |
See all 6 services
| Long return visit (40+ min) | 32 | $6,128 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,298 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $2,018 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,262 | $115 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 14 | $430 | $31 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 20 | $383 | $14 |
Who their Medicare patients are
76 Original Medicare patients in 2024. Average age 70 · Under 65 25% · 85 and older 14% · Women 41% · Also on Medicaid 41% · Health risk score 2.41. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 47% · Chronic kidney disease 43% · Coronary heart disease 34% · Atrial fibrillation 32% · Depression 32% · Heart failure 28% · Cancer 21% · COPD 21% · Dementia 14%.
The office billed $101,096, Medicare allowed $20,177 and paid $14,587; for 186 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 76 | 186 | 70 | 2.41 | $101,096 | $14,587 |
| 2023 | 147 | 328 | 70 | 2.77 | $205,642 | $31,376 |
| 2022 | 155 | 382 | 68 | 2.92 | $250,497 | $40,697 |
| 2021 | 142 | 310 | 69 | 3.13 | $196,781 | $32,378 |
| 2020 | 86 | 182 | 67 | 2.83 | $89,873 | $17,227 |
| 2019 | 12 | 21 | 61 | 2.79 | $3,812 | $1,721 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 49 | $12,764 | $112 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $5,996 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $4,770 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,164 | $105 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,645 | $115 |
2022: 5 services
| Long return visit (40+ min) | 64 | $16,319 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $10,005 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,663 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,586 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,427 | $119 |
2021: 7 services
| Long return visit (40+ min) | 52 | $10,048 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $7,941 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,906 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,613 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,697 | $121 |
| New patient visit (60+ min) | 13 | $1,406 | $108 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,282 | $85 |
2020: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $6,120 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,218 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,898 | $63 |
Medicaid work
$3,471 in 2023
Medicaid paid $3,471 for 28 billed services this clinician did in 2023, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 28 | $3,471 |
| 2023 | 28 | 1 | 16 | $3,471 |
| 2022 | 52 | 1 | 13 | $3,619 |
| 2021 | 29 | 1 | 17 | $1,833 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 52 | $3,619 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 29 | $1,833 |
Drugs they prescribed that Part D paid
$406,107
Pharmacies billed $406,107 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
387 generic and 133 brand-name prescriptions · $406,107 in drug cost · 105 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 34 | $139,816 | $4,112 |
| Triumeq | 16 | $57,519 | $3,595 |
| Doxycycline Monohydrate | 16 | $382 | $24 |
| Sulfamethoxazole-Trimethoprim | 23 | $351 | $15 |
| Mirtazapine | 22 | $219 | $10 |
See all 13 drugs
| Biktarvy | 34 | $139,816 | $4,112 |
| Triumeq | 16 | $57,519 | $3,595 |
| Doxycycline Monohydrate | 16 | $382 | $24 |
| Sulfamethoxazole-Trimethoprim | 23 | $351 | $15 |
| Mirtazapine | 22 | $219 | $10 |
| Valacyclovir | 12 | $194 | $16 |
| Levofloxacin | 11 | $163 | $15 |
| Tamsulosin | 14 | $144 | $10 |
| Atorvastatin | 43 | $84 | $2 |
| Alendronate | 27 | $67 | $2 |
| Lisinopril | 11 | $22 | $2 |
| Famotidine | 11 | $18 | $2 |
| Amlodipine Besylate | 14 | $9 | $1 |
Year by year
| 2024 | 520 | 44 | None | 26% | $406,107 |
| 2023 | 686 | 45 | None | 35% | $764,209 |
| 2022 | 696 | 56 | None | None | $613,802 |
| 2021 | 221 | 40 | 0% (0) | 23% | $168,804 |
| 2020 | 105 | 19 | 0% (0) | 47% | $128,582 |
| 2019 | 168 | 19 | 0% (0) | 47% | $205,094 |
| 2018 | 179 | 24 | None | 47% | $185,238 |
| 2017 | 99 | 27 | 0% (0) | 27% | $35,155 |
| 2016 | 89 | 23 | None | None | $4,068 |
| 2015 | 221 | 39 | 5% (11) | None | $18,430 |
| 2014 | 143 | 35 | 11% (15) | 22% | $9,715 |
| 2013 | 39 | 16 | None | 31% | $2,498 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Biktarvy | 68 | $307,011 | $4,515 |
| Triumeq | 32 | $123,154 | $3,849 |
| Symtuza | 14 | $70,539 | $5,038 |
| Odefsey | 12 | $45,928 | $3,827 |
| Tivicay | 13 | $28,471 | $2,190 |
| Pifeltro | 11 | $20,651 | $1,877 |
| Trulicity | 14 | $13,690 | $978 |
| Lamivudine | 12 | $2,642 | $220 |
| Valacyclovir | 33 | $1,741 | $53 |
| Sulfamethoxazole-Trimethoprim | 26 | $878 | $34 |
| Clindamycin | 21 | $873 | $42 |
| Methenamine Hippurate | 11 | $841 | $76 |
| Doxycycline Monohydrate | 19 | $717 | $38 |
| Mirtazapine | 21 | $631 | $30 |
| Vancomycin | 12 | $550 | $46 |
| Metformin | 20 | $493 | $25 |
| Atorvastatin | 23 | $439 | $19 |
| Doxycycline Hyclate | 16 | $404 | $25 |
| Amlodipine Besylate | 18 | $326 | $18 |
| Bisoprolol | 13 | $246 | $19 |
| Omeprazole | 13 | $246 | $19 |
| Allopurinol | 13 | $231 | $18 |
| Levofloxacin | 12 | $190 | $16 |
| Losartan | 12 | $163 | $14 |
| Minocycline | 13 | $146 | $11 |
2022: 30 drugs
| Biktarvy | 33 | $154,591 | $4,685 |
| Symtuza | 18 | $83,445 | $4,636 |
| Triumeq | 22 | $75,186 | $3,418 |
| Dovato | 13 | $38,771 | $2,982 |
| Odefsey | 11 | $38,616 | $3,511 |
| Juluca | 11 | $36,666 | $3,333 |
| Prezista | 12 | $25,331 | $2,111 |
| Tivicay | 11 | $22,302 | $2,027 |
| Pifeltro | 12 | $21,716 | $1,810 |
| Edurant | 11 | $14,237 | $1,294 |
| Serevent Diskus | 11 | $4,711 | $428 |
| Testosterone | 16 | $3,614 | $226 |
| Vancomycin | 23 | $2,978 | $129 |
| Imipenem-Cilastatin | 27 | $2,916 | $108 |
| Arnuity Ellipta | 11 | $2,182 | $198 |
| Valacyclovir | 20 | $1,282 | $64 |
| Omega-3 Acid Ethyl Esters | 13 | $1,216 | $94 |
| Clindamycin | 17 | $1,147 | $67 |
| Sulfamethoxazole-Trimethoprim | 24 | $715 | $30 |
| Doxycycline Monohydrate | 16 | $679 | $42 |
| Levofloxacin | 14 | $276 | $20 |
| Metformin | 14 | $224 | $16 |
| Atorvastatin | 22 | $201 | $9 |
| Bisoprolol | 11 | $193 | $18 |
| Pregabalin | 13 | $181 | $14 |
| Amoxicillin | 16 | $112 | $7 |
| Lisinopril | 11 | $90 | $8 |
| Allopurinol | 11 | $79 | $7 |
| Amlodipine Besylate | 11 | $79 | $7 |
| Omeprazole | 11 | $79 | $7 |
2021: 4 drugs
| Biktarvy | 15 | $72,488 | $4,833 |
| Daptomycin | 15 | $6,989 | $466 |
| Sulfamethoxazole-Trimethoprim | 22 | $440 | $20 |
| Levofloxacin | 13 | $205 | $16 |
2020: 3 drugs
| Biktarvy | 12 | $41,931 | $3,494 |
| Dovato | 13 | $33,105 | $2,547 |
| Prezista | 12 | $22,381 | $1,865 |
2019: 6 drugs
| Biktarvy | 21 | $65,655 | $3,126 |
| Triumeq | 22 | $65,533 | $2,979 |
| Prezista | 12 | $20,493 | $1,708 |
| Descovy | 11 | $19,378 | $1,762 |
| Ritonavir | 12 | $781 | $65 |
| Amoxicillin | 16 | $335 | $21 |
2018: 8 drugs
| Genvoya | 28 | $84,278 | $3,010 |
| Triumeq | 18 | $53,261 | $2,959 |
| Descovy | 12 | $20,385 | $1,699 |
| Prezista | 12 | $19,228 | $1,602 |
| Terazosin | 11 | $60 | $5 |
| Lisinopril | 15 | $42 | $3 |
| Finasteride | 11 | $37 | $3 |
| Amlodipine Besylate | 12 | $21 | $2 |
2017: 1 drug
| Sertraline | 14 | $33 | $2 |
2015: 4 drugs
| Polyethylene Glycol 3350 | 17 | $573 | $34 |
| Atorvastatin | 12 | $99 | $8 |
| Jantoven | 13 | $68 | $5 |
| Hydrochlorothiazide | 13 | $43 | $3 |
2014: 2 drugs
| Polyethylene Glycol 3350 | 11 | $599 | $54 |
| Hydrochlorothiazide | 11 | $53 | $5 |
Professional record
- NPI
- 1649513805
- Licence
- CA A169620, RI CLP03370, RI MD15835California A169620: Current · expires 2028-08-31
- Group
- Regents of the University of California · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Internal medicine (207R00000X); Pediatrics (208000000X)
- Mailing address
- 513 Parnassus Ave, # 380, San Francisco, CA, 94143
- NPI first listed
- 2013-04-05
- NPI last updated
- 2020-08-20
- NPI record certified
- 2020-08-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 593 Eddy St, Providence, RI, 02903